Skip to main content
. Author manuscript; available in PMC: 2014 Nov 1.
Published in final edited form as: Circ Cardiovasc Imaging. 2013 Oct 4;6(6):1001–1008. doi: 10.1161/CIRCIMAGING.112.000328

Table 3.

Predictors of Adverse Outcome

Baselines values No events
(n=83)
Events
(n=45)
Hazard Ratio*
(95% CI)
p Value
Age (years) 44.9 ± 10.8 37.9 ± 10.7 0.59 (0.43 – 0.80) 0.001
NYHA class III–IV (n/%) 8 (10) 11 (24) 2.80 (1.40 – 5.58) 0.003
Loud P2 (n/%) 27 (32) 25 (55) 3.92 (2.0 – 7.68) <0.001
Atrial fibrillation (n/%) 13 (16) 5 (11) 0.66 (0.26 – 1.67) 0.38
LAV index (mL/m2) 49.4 ± 15.5 56.9 ± 14.3 1.37 (1.04 – 1.79) 0.010
RVMPI 0.29 ± 0.12 0.33 ± 0.11 1.41 (1.04 – 1.91) 0.026
Peak gradient (mmHg) 15.2 ± 5.8 24.2 ± 9.2 2.19 (1.73 – 2.76) <0.001
Mean gradient (mmHg) 8.2 ± 3.9 14.7 ± 6.4 2.09 (1.71 – 2.57) <0.001
MV area (cm2) 1.4 ± 0.3 0.9 ± 0.2 0.13 (0.07 – 0.23) <0.001
SPAP (mmHg) 36.9 ± 13.2 56.9 ± 22.6 1.93 (1.54 – 2.40) <0.001
Cn (mL/mmHg) 5.1 ± 1.1 3.8 ± 1.2 0.30 (0.19 – 0.47) <0.001

Data are expressed as the mean value ± SD or number (percentage) of patients.

*

hazard ratio per 1 SD increase

Cn = net atrioventricular compliance; LAV = left atrial volume; MV = mitral valve; P2 = pulmonic valve closure sound; RVMPI = Right ventricular myocardial performance index; SPAP = systolic pulmonary artery pressure